← Back to directory

Cord Sunderkötter

Researcher Next ID · RN-032002

Researcher · Biochemistry, Genetics and Molecular Biology

MSB Medical School Berlin

Berlin, Germany

Accepting doctoral researchersFunding unknown
Works count
4,730
Citation count
19,855
H-index
69
i10-index
249

Research interests

Biochemistry, Genetics and Molecular Biology
Immunology and Microbiology
Medicine
Metabolism and Genetic Disorders
Autoimmune Bullous Skin Diseases
Vasculitis and related conditions
Systemic Sclerosis and Related Diseases
Immunodeficiency and Autoimmune Disorders

Publications

  • Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

    Journal of Clinical Oncology · 2019 · 10.1200/jco.18.02306

  • Nomenclature of Cutaneous Vasculitis

    Arthritis & Rheumatology · 2017 · 10.1002/art.40375

  • European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes

    Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14458

  • European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis

    Journal of the European Academy of Dermatology and Venereology · 2017 · https://doi.org/10.1111/jdv.14466

  • Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial

    The Lancet Oncology · 2016 · 10.1016/s1470-2045(16)00141-8

  • Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”

    JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2013 · 10.1111/ddg.12113_suppl

  • Frequency of disease-associated and other nuclear autoantibodies in patients of the German network for systemic scleroderma: correlation with characteristic clinical features

    Arthritis Research & Therapy · 2011 · 10.1186/ar3495

  • An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice

    Journal of Clinical Investigation · 2011 · 10.1172/jci44490

  • Targeting the Neurokinin Receptor 1 with Aprepitant: A Novel Antipruritic Strategy

    PLoS ONE · 2010 · https://doi.org/10.1371/journal.pone.0010968

  • The endogenous Toll–like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer

    Journal of Leukocyte Biology · 2009 · 10.1189/jlb.1008647

  • The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement

    Lara D. Veeken · 2008 · 10.1093/rheumatology/ken179

  • Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes

    Blood · 2006 · 10.1182/blood-2006-02-001115

  • Uptake of Leishmania major by dendritic cells is mediated by Fcγ receptors and facilitates acquisition of protective immunity

    The Journal of Experimental Medicine · 2006 · 10.1084/jem.20052288

  • Decorin, a Novel Player in the Insulin-like Growth Factor System

    Journal of Biological Chemistry · 2005 · 10.1074/jbc.m500451200

  • Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response

    The Journal of Immunology · 2004 · 10.4049/jimmunol.172.7.4410

  • Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules

    Trends in Immunology · 2003 · 10.1016/s1471-4906(03)00062-0

  • Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis

    Arthritis & Rheumatism · 2000 · 10.1002/1529-0131(200003)43:3<628::aid-anr20>3.0.co;2-x

  • Macrophages and angiogenesis

    Journal of Leukocyte Biology · 1994 · 10.1002/jlb.55.3.410

  • Macrophage-derived angiogenesis factors

    Pharmacology & Therapeutics · 1991 · 10.1016/0163-7258(91)90077-y

Current projects

    No projects listed.